About: http://data.cimple.eu/news-article/e16762817d86ca7712491dd68977609a6d0658ba693e82f11e80f832

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/e16762817d86ca7712491dd68977609a6d0658ba693e82f11e80f832 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The United States should resume Johnson & Johnson Covid-19 vaccinations, an expert panel recommended to health authorities on Friday, after a pause prompted by blood clot concerns. Health authorities in the United States on April 14 proposed a halt on the vaccine following instances of severe blood clots among the millions of Americans who received the vaccine. The panel was 10 to 4 in favor of recommending the lifting of the pause, but the head of the Centers for Disease Control and Prevention (CDC) Rochelle Walensky will make the final decision. "The Janssen Covid-19 vaccine is recommended for persons 18 years of age and older in the US population under the FDA, emergency use authorization," the experts convened by the CDC said. According to data presented Friday, of 3.9 million women who got the Johnson & Johnson shot, 15 developed serious blood clots and three died. The majority of the confirmed cases, 13 of the 15, was aged under 50 years old. There were no reported cases among men. Experts voiced support for the vaccine in a nation where over 570,000 people have died from the virus, the largest reported absolute death toll in the world. "Removing a vaccine that can be given as a single dose and is a preference among Latinos in our communities, would be a detriment," said Dr Jose Romero, chairman of CDC Advisory Committee on Immunization Practices. Johnson & Johnson's chief scientific officer Paul Stoffels welcomed the recommendation, saying it "is an essential step toward continuing urgently needed vaccinations in a safe way for millions of people in the US". Europe's medicines regulator said Tuesday that blood clots should be listed as a "very rare" side effect of Johnson & Johnson's coronavirus vaccine. The regulator said its safety committee "concluded that a warning about unusual blood clots with low blood platelets should be added to the product information" for the J&J shot. cyj/jm/mdl
schema:headline	US experts recommend resuming J&J Covid vaccinations
schema:mentions	Thrombosis Johnson & Johnson Thrombus Ebola virus disease Food and Drug Administration Centers for Disease Control and Prevention European Union Coronavirus disease Vaccine United States Coronavirus disease 2019 Jose Romero (Australian footballer) Paul Stoffels Platelet The Panel (Australian TV series)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-04-23 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	82 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software